ENFORCE
01/17/1996

 ENFORCEMENT REPORT FOR 01/17/96 


January 17, 1996                             96-03

RECALLS AND FIELD CORRECTIONS:  DRUGS -- CLASS II ===========
_______________
PRODUCT        On the Spot brand Acne Treatment Creams, OTC
               drugs in 0.75 ounce tubes:  (a) Vanishing
               Formula; (b) Tinted Formula.  
               Recall #D-067/068-6.
CODE           Lot numbers:  (a) 1G5 EXP 8/97; 
               (b) 1J5 EXP 9/97.
MANUFACTURER   Packaging Advantage Corporation, Los Angeles,
               California.
RECALLED BY    Neutrogena Corporation, Los Angeles,
               California, by letter on October 11, 1995. 
               Firm-initiated recall complete.
DISTRIBUTION   Nationwide and international.
QUANTITY       (a) 8,307 dozen tubes; (b) 3,475 dozen tubes
               were distributed.
REASON         Presence of Pseudomonas cepacia.

_______________
PRODUCT        Indomethacin Sustained Release Capsules USP,
               75 mg, Rx oral nonsteroidal anti-inflammatory
               used in treatment of moderate to severe
               rheumatoid arthritis.  Recall #D-072-6.
CODE           Lot numbers:  4230133 and 4315115.
MANUFACTURER   Inwood Laboratories, Inc., Inwood, New York.
RECALLED BY    Allscrips Pharmaceuticals, Inc., Vernon Hills,
               Illinois (repacker), by letter dated May 17,
               1995.  Firm-initiated recall complete.
DISTRIBUTION   Missouri, New Mexico, Wyoming, New Jersey,
               Washington, D.C., Michigan, Texas, Illinois,
               Colorado.
QUANTITY       73 bottles of 14 capsules and 31 bottles of 10
               capsules were distributed.
REASON         Product does not meet dissolution
               specifications.

_______________
PRODUCT        Searle Calan Tablets, Verapamil Hydrochloride
               (a) 40 mg, in 100 tablet bottles; (b) 80 mg,
               in 100, 500, and 1000 tablet bottles, an
               immediate action Rx oral calcium slow-channel
               blocker for treatment of angina arrhythmias
               and essential hypertension.  
               Recall #D-073/074-6.
CODE           (a) 3K044, 4F050, 4L051, 4P052, 4P052A; 
               (b) 3P455, 4B457, 4C458, 4C459.
MANUFACTURER   G.D. Searle & Company, Caguas, Puerto Rico.
RECALLED BY    G.D. Searle & Company, Skokie, Illinois, by
               letter dated January 8, 1996.  Firm-initiated
               recall ongoing.
DISTRIBUTION   Nationwide.
QUANTITY       (a) 98,405 100-tablet bottles; (b) 58,974 100-
               tablet bottles, 1,000 500-tablet bottles, and
               5,453 1000-tablet bottles were distributed;
               firm estimated that 10 percent of the product
               remained on market at time of recall
               initiation.
REASON         Products may not meet dissolution
               specifications.

_______________
PRODUCT        Novopharm Piroxicam Capsules, USP, 20 mg, Rx
               oral anti-inflammatory/analgesic, in bottles
               of 100 capsules.  Recall #D-075-6.
CODE           Lot #5515240.
MANUFACTURER   Novopharm Ltd., Scarborough, Ontario, Canada.
RECALLED BY    Novopharm, Inc., Schaumburg, Illinois, by
               letter dated January 9, 1996.  Firm-initiated
               recall ongoing.
DISTRIBUTION   Nationwide.
QUANTITY       4,743 bottles were distributed; firm estimated
               that very little if any of the product
               remained on market at time of recall
               initiation.
REASON         product does not meet dissolution
               specifications.

                             -2-_______________
PRODUCT        Oxygen USP in steel and aluminum high pressure
               cylinders, sizes E, D, B, M6, and N. 
               Recall #D-076-6.
CODE           Al lot numbers beginning with 07, 08, 09, 10,
               11, and 12.
MANUFACTURER   Home Oxygen Medical Equipment, Inc., Oswego,
               New York.
RECALLED BY    Manufacturer, by visit.  Firm-initiated recall
               ongoing.
DISTRIBUTION   New York.
QUANTITY       Several hundred cylinders were distributed.
REASON         Current good manufacturing practice (CGMP)
               deficiencies.


RECALLS AND FIELD CORRECTIONS:  DRUGS -- CLASS  III =========
_______________
PRODUCT        Novadyne Expectorant, antitussive,
               decongestant in 4 fluid ounce, pint, and
               gallon size containers, under the H N Norton
               and Goldline labels.  Recall #D-069-6.
CODE           Lot #6564 EXP 12/95.
MANUFACTURER   Zenith Goldline - Shreveport, Shreveport,
               Louisiana.
RECALLED BY    Manufacturer, by letter dated December 5,
               1995.  Firm-initiated recall ongoing.
DISTRIBUTION   Nationwide.
QUANTITY       Norton:  11,811 4-fluid ounce size;  
               1,986 pint size; 95 gallons size
               Goldline:  13,980 4-fluid ounce size
               5,688 pint size were distributed.
REASON         Product does not meet Codeine Phosphate
               specifications through expiration date.

_______________
PRODUCT        Chemdal HD Liquid, antitussive, decongestant,
               in pint and gallon size containers, under the
               H N Norton, Goldline, and Major labels.
               Recall #D-070-6.
CODE           Lot #7724.
MANUFACTURER   Zenith Goldline Pharmaceuticals, Shreveport,
               Louisiana.
RECALLED BY    Manufacturer, by letter on December 6, 1995. 
               Firm-initiated recall ongoing.
DISTRIBUTION   Nationwide.
QUANTITY       HN Norton/LuChem:  1,976 pints and 398 gallons
               Goldline: 2,447 pints
               Major:  6,621 pints were distributed.
REASON         Product does not meet Phenylephrine HCl
               specifications through expiration date.

                             -3-_______________
PRODUCT        Isoniazid Tablets USP, 100 mg, Rx oral anti-
               tuberculin, in bottles of 30 and 100 tablets. 
               Recall #D-071-6.
CODE           Lot numbers:  2231133 and 4046112.
MANUFACTURER   Barr Laboratories, Inc., Pomona, New York.
RECALLED BY    Allscrips Pharmaceuticals, Inc., Vernon Hills,
               Illinois (repacker), by letters dated April
               27, 1995 and November 27, 1995.  Firm-
               initiated recall complete.
DISTRIBUTION   California and Georgia.
QUANTITY       59 bottles of 30 tablets and 6 bottles of 100
               tablets were distributed.
REASON         Product does not meet dissolution
               specifications at the 48 and 60 month test
               intervals.

                             -4-


END OF ENFORCEMENT REPORT FOR JANUARY 17, 1996.  BLANK PAGES MAY
FOLLOW.

                                   ####